Gianluca Spitaleri - New Drugs Development and Clinical Pharmacology Unit, European Institute of Oncology (IEO)

基本信息

浏览量：97

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 168 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

27P CNS-progression Patterns in Patients with EGFR-mutant NSCLC Receiving Standard Platinum-Based Chemotherapy Post-Osimertinib

I. Attili, C. Corvaja,G. Spitaleri, P.M. Trillo Aliaga,E. Del Signore,A. Passaro,F. de Marinis

ESMO Open (2024)

引用0浏览0引用

Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings

Ilaria Attili,Carla Corvaja,Gianluca Spitaleri,Pamela Trillo Aliaga,Ester Del Signore,Antonio Passaro,Filippo de Marinis

CANCERSno. 14 (2024)

引用0浏览0WOS引用

Non-Small-Cell Lung Cancers (nsclcs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “shadows and Fogs”

Gianluca Spitaleri,Pamela Trillo Aliaga,Ilaria Attili,Ester Del Signore,Carla Corvaja,Gloria Pellizzari, Jalissa Katrini,Antonio Passaro,Filippo de Marinis

Cancersno. 16 (2024)

引用0浏览0WOS引用

Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: an Evolving Scenario

Valeria Fuorivia,Ilaria Attili,Carla Corvaja, Riccardo Asnaghi,Ambra Carnevale Schianca,Pamela Trillo Aliaga,Ester Del Signore,Gianluca Spitaleri,Antonio Passaro,Filippo de Marinis

Current Oncologyno. 9 (2024): 5121-5139

引用0浏览0WOS引用

Alectinib Vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences Across ALEX and CROWN Phase 3 Trials

Ilaria Attili, Valeria Fuorivia,Gianluca Spitaleri,Carla Corvaja,Pamela Trillo Aliaga,Ester Del Signore, Riccardo Asnaghi,Ambra Carnevale Schianca,Antonio Passaro,Filippo de Marinis

Cancersno. 13 (2024): 2457

引用0浏览0WOS引用

Advancements in Fourth-Generation EGFR TKIs in EGFR-mutant NSCLC: Bridging Biological Insights and Therapeutic Development

Carla Corvaja,Antonio Passaro,Ilaria Attili,Pamela Trillo Aliaga,Gianluca Spitaleri,Ester Del Signore,Filippo de Marinis

Cancer Treatment Reviewspp.102824, (2024)

引用0浏览0WOS引用

Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis

Ilaria Attili, Riccardo Asnaghi,Davide Vacirca, Riccardo Adorisio,Alessandra Rappa,Alberto Ranghiero, Mariano Lombardi,Carla Corvaja, Valeria Fuorivia,Ambra Carnevale Schianca,Pamela Trillo Aliaga,Gianluca Spitaleri,Ester Del Signore,Juliana Guarize,Lorenzo Spaggiari,Elena Guerini-Rocco,Nicola Fusco,Filippo de Marinis,Antonio Passaro

JOURNAL OF CLINICAL MEDICINEno. 15 (2024)

引用0浏览0WOS引用

The Evolving Scenario of ES-SCLC Management: from Biology to New Cancer Therapeutics

Pamela Trillo Aliaga,Ester Del Signore, Valeria Fuorivia,Gianluca Spitaleri, Riccardo Asnaghi,Ilaria Attili,Carla Corvaja,Ambra Carnevale Schianca,Antonio Passaro,Filippo de Marinis

Genesno. 6 (2024): 701-701

引用0浏览0WOS引用

Trying to Protect HT Patients Poor Vaccine Responders: Reducing MMF or Trust Tixagevimab/Cilgavimab? Insights from CONTRAST Study

M. Masetti,M. Scuppa,L. Giovannini,L. Borgese, A. Aloisio,G. Spitaleri,M. Giannella,L. Potena

JOURNAL OF HEART AND LUNG TRANSPLANTATIONno. 4 (2023): S263-S264

引用0浏览0引用

Immune Checkpoint Inhibitors in EGFR-mutant Non-Small Cell Lung Cancer: A Systematic Review

Ilaria Attili,Antonio Passaro,Carla Corvaja,Pamela Trillo Aliaga,Ester Del Signore,Gianluca Spitaleri,Filippo de Marinis

Cancer treatment reviews（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn